Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Inflammation Drives Coagulopathies in Sars-Cov-2 Patients

Martha MS Sim, MSc, Meenakshi Banerjee, PhD, Melissa Hollifield, MSc, Hammodah Alfar, Xian Li, PhD, Alice Thornton, MD, James Z Porterfield, MD, Jamie Sturgill, PhD, Gail A Sievert, Marietta Barton-Baxter, Kenneth S Campbell, PhD, Jerold G Woodward, PhD, Sidney W Whiteheart, PhD, Beth A Garvy, PhD, Jeremy P Wood, PhD

Blood (2020) 136 (Supplement 1): 34–35.

https://doi.org/10.1182/blood-2020-142848

Published: 2020

Journal Articles

Antiretroviral Therapy Does Not Correct the Increased Thrombin Generation and Platelet Hyperactivity Associated with HIV

Meenakshi Banerjee, PhD, Martha Sim, Thein Myint, MD, Sidney W. Whiteheart, PhD, Jeremy P. Wood, PhD

Blood (2019) 134 (Supplement_1): 3659.

https://doi.org/10.1182/blood-2019-130070

Published: 2019

Journal Articles

Protein S Coordinates the Inhibition of Prothrombinase By Tfpiα and Activated Protein C

Xian Li, PhD, Sara J Bidarian, Martha Sim, Xiaohong Song, Jeremy P. Wood, PhD

Blood (2019) 134 (Supplement_1): 2386.

https://doi.org/10.1182/blood-2019-130799

Published: 2019

Journal Articles

Platelet CD36 Promotes ERK5 and Caspase-Dependent Procoagulant Phosphatidylserine Externalization and In Vivo Fibrin Formation in Dyslipidemia

Moua Yang, PhD, Andaleb Kholmukhamedov, MD, Marie L Schulte, PhD, Brian C Cooley, PhD, Na'il O Scoggins, Jeremy P. Wood, PhD, Scott J Cameron, MDPhD, Craig Morrell, DVM, PhD, Shawn M. Jobe, MD PhD, Roy L. Silverstein, MD

Blood (2018) 132 (Supplement 1): 867.

https://doi.org/10.1182/blood-2018-99-111204

Published: 2018

Journal Articles

BFPI: A Minimal Prothrombinase Inhibitor from the Saliva of Simulium Vittatum

Jeremy P. Wood, PhD, Xiao H. Song, Alan E. Mast, MDPhD

Blood (2018) 132 (Supplement 1): 1163.

https://doi.org/10.1182/blood-2018-99-118666

Published: 2018

Journal Articles

Prothrombinase Inhibition By Tfpiα Requires Three Distinct Interactions with Factors Va and X

Jeremy P. Wood, PhD, Alan E. Mast, MDPhD

Blood (2017) 130 (Supplement 1): 1060.

https://doi.org/10.1182/blood.V130.Suppl_1.1060.1060

Published: 2017

Journal Articles

Laboratory Assays to Address the Problem of Heparin-Protamine Balance Following Neonatal Open Heart Surgery

Julie A. Peterson, PhD, Susan A. Maroney, DVM, PhD, Wes Zwifelhofer, BS, Jeremy P. Wood, PhD, Rachel Bercovitz, MD MS, Ronald K. Woods, MD PhD, Alan E. Mast, MDPhD

Blood (2017) 130 (Supplement 1): 1111.

https://doi.org/10.1182/blood.V130.Suppl_1.1111.1111

Published: 2017

Journal Articles

TFPIα Has Reduced Ability to Inhibit FV Leiden

Jeremy P. Wood, PhD, Lisa Baumann Kreuziger, MD, Rodney M. Camire, PhD, Alan E. Mast, MD PhD

Blood (2015) 126 (23): 423.

https://doi.org/10.1182/blood.V126.23.423.423

Published: 2015

Journal Articles

Plasma and Platelet Tissue Factor Pathway Inhibitor (TFPI) in Blood Donors and in People with Hemophilia

Paul E. R. Ellery, PhD, Cecilia Augustsson, PhD, Soren Andersen, PhD, Susan A. Maroney, DVM, PhD, Jeremy P Wood, PhD, Joan Cox Gill, MD, Ida Hilden, PhD, Alan E. Mast, MD PhD

Blood (2014) 124 (21): 4241.

https://doi.org/10.1182/blood.V124.21.4241.4241

Published: 2014

Journal Articles

Relieving Inhibition of Prothrombinase By TFPIα: a Procoagulant Activity of Unfractionated, Low Molecular Weight, and Nonanticoagulant Heparins

Jeremy P Wood, PhD, Lisa M Baumann Kreuziger, MD, Rodney M. Camire, PhD, Umesh R Desai, PhD, Alan E. Mast, MD PhD

Blood (2014) 124 (21): 1478.

https://doi.org/10.1182/blood.V124.21.1478.1478

Published: 2014

Journal Articles

Specific Leucine, Isoleucine and Threonine Residues In The TFPIα C-Terminal Region Are Necessary For Inhibition Of Prothrombinase

Jeremy P Wood, PhD, Alan E. Mast, MD, PhD

Blood (2013) 122 (21): 3562.

https://doi.org/10.1182/blood.V122.21.3562.3562

Published: 2013

Journal Articles

Protein S Is a Cofactor for Platelet TFPIα, but Not Cell Surface-Associated TFPI

Jeremy P. Wood, PhD, Paul E. R. Ellery, PhD, Susan A. Maroney, DVM, PhD, Alan E. Mast, MD, PhD

Blood (2012) 120 (21): 494.

https://doi.org/10.1182/blood.V120.21.494.494

Published: 2012

NARROW

Inflammation Drives Coagulopathies in Sars-Cov-2 Patients

Antiretroviral Therapy Does Not Correct the Increased Thrombin Generation and Platelet Hyperactivity Associated with HIV

Protein S Coordinates the Inhibition of Prothrombinase By Tfpiα and Activated Protein C

Platelet CD36 Promotes ERK5 and Caspase-Dependent Procoagulant Phosphatidylserine Externalization and In Vivo Fibrin Formation in Dyslipidemia

BFPI: A Minimal Prothrombinase Inhibitor from the Saliva of Simulium Vittatum

Prothrombinase Inhibition By Tfpiα Requires Three Distinct Interactions with Factors Va and X

Laboratory Assays to Address the Problem of Heparin-Protamine Balance Following Neonatal Open Heart Surgery

TFPIα Has Reduced Ability to Inhibit FV Leiden

Plasma and Platelet Tissue Factor Pathway Inhibitor (TFPI) in Blood Donors and in People with Hemophilia

Relieving Inhibition of Prothrombinase By TFPIα: a Procoagulant Activity of Unfractionated, Low Molecular Weight, and Nonanticoagulant Heparins

Specific Leucine, Isoleucine and Threonine Residues In The TFPIα C-Terminal Region Are Necessary For Inhibition Of Prothrombinase

Protein S Is a Cofactor for Platelet TFPIα, but Not Cell Surface-Associated TFPI

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only